Table 2.
Univariate analysis | Multivariate analysis (n = 112) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
variables | n | estimates | S.E. | HR | 95% CI | p | estimates | S.E. | HR | 95% CI | p |
QLQ-C15-PAL | |||||||||||
Physical Functioning | 125 | −0.001 | 0.004 | 0.999 | 0.991–1.006 | .738 | |||||
Emotional Functioning | 129 | 0.001 | 0.003 | 1.001 | 0.994–1.008 | .809 | |||||
Dyspnea | 130 | 0.010 | 0.003 | 1.010 | 1.005–1.016 | < .001** | 0.012 | 0.003 | 1.012 | 1.005–1.019 | < .001** |
Pain | 129 | −0.0004 | 0.003 | 1.000 | 0.994–1.005 | .878 | |||||
Insomnia | 130 | 0.001 | 0.003 | 1.001 | 0.996–1.006 | .608 | |||||
Appetite Loss | 130 | 0.005 | 0.003 | 1.005 | 1.000–1.010 | .073 | |||||
Constipation | 128 | 0.0003 | 0.003 | 1.000 | 0.995–1.006 | .922 | |||||
Fatigue | 129 | 0.011 | 0.003 | 1.011 | 1.004–1.017 | .002** | 0.009 | 0.004 | 1.009 | 1.001–1.016 | .024* |
Nausea/Vomiting | 130 | 0.002 | 0.003 | 1.002 | 0.995–1.008 | .597 | |||||
QOL | 124 | −0.007 | 0.004 | 0.993 | 0.986–1.000 | .055 | |||||
Inflammatory Biomarkers | |||||||||||
CRP | 126 | 0.049 | 0.014 | 1.050 | 1.022–1.079 | < .001** | |||||
Alb | 126 | −0.465 | 0.171 | 0.628 | 0.449–0.878 | .007** | −0.457 | 0.180 | 0.633 | 0.445–0.902 | .011* |
NLR | 122 | 0.017 | 0.003 | 1.017 | 1.012–1.023 | < .001** | 0.015 | 0.003 | 1.015 | 1.009–1.021 | < .001** |
*p < .05, **p < .01; estimates = regression coefficients, S.E.: Standard errors of estimates; all QLQ-C15-PAL scale scores were linearly transformed, and the resultant scores ranged from 0 to 100. Alb albumin, CI confidence interval, CRP C-reactive protein, HR hazard ratio, NLR neutrophil-lymphocyte ratio, QLQ-C15-PAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care, QOL quality of life